BioPharma Dive October 11, 2024
The French pharmaceutical giant said it’s in negotiations to sell a controlling stake of Opella to the private equity firm CD&R, in a deal that reportedly could be worth more than $16 billion.
For the past year, French pharmaceutical giant Sanofi has been searching for a buyer to take control of its consumer health business. That search may now be over.
On Friday, Sanofi said it’s in negotiations with the private equity firm Clayton Dubilier & Rice for the potential sale of a 50% controlling stake in the consumer business, named Opella. Financial terms of the deal weren’t disclosed. However, Reuters, citing a person familiar with the matter, reported a day earlier that the two parties were closing in on...
Today's Sponsors
Today's Sponsor